Concord Drugs Limited (CONCORD.BO)
INR 36.45
(-2.72%)
INR 36.45
(-2.72%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 588.06 Million INR | 0.99% |
| 2022 | 582.31 Million INR | 3.16% |
| 2021 | 564.45 Million INR | 13.16% |
| 2020 | 498.82 Million INR | -14.02% |
| 2019 | 580.15 Million INR | -29.91% |
| 2018 | 827.68 Million INR | -22.22% |
| 2017 | 1.06 Billion INR | 41.84% |
| 2016 | 750.26 Million INR | 43.42% |
| 2015 | 523.12 Million INR | -3.51% |
| 2014 | 542.15 Million INR | 21.33% |
| 2013 | 446.83 Million INR | 8.64% |
| 2012 | 411.3 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 589.04 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 588.06 Million INR | 0.0% |
| 2023 FY | 588.06 Million INR | 0.99% |
| 2022 FY | 582.31 Million INR | 3.16% |
| 2022 Q2 | 538.93 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 582.31 Million INR | 0.0% |
| 2021 Q2 | 515.94 Million INR | 0.0% |
| 2021 FY | 564.45 Million INR | 13.16% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 564.45 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q2 | 630.3 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 498.82 Million INR | -14.02% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 498.82 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 580.15 Million INR | -29.91% |
| 2019 Q4 | 580.15 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 731.02 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 1.08 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 827.68 Million INR | -22.22% |
| 2018 Q4 | 827.68 Million INR | 0.0% |
| 2017 Q4 | 1.06 Billion INR | 0.0% |
| 2017 Q2 | 899.53 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 1.06 Billion INR | 41.84% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 750.26 Million INR | 43.42% |
| 2016 Q4 | 747.52 Million INR | 0.0% |
| 2016 Q2 | 644.84 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 546.05 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 523.12 Million INR | -3.51% |
| 2015 Q4 | 525.26 Million INR | 0.0% |
| 2014 Q4 | 542.15 Million INR | 0.0% |
| 2014 Q2 | 423.64 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 542.15 Million INR | 21.33% |
| 2013 Q4 | 446.83 Million INR | 0.0% |
| 2013 FY | 446.83 Million INR | 8.64% |
| 2012 Q4 | 411.3 Million INR | 0.0% |
| 2012 FY | 411.3 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 33.74 Million INR | -1642.773% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | 41.174% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -55.101% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -57.645% |
| Sunil Healthcare Limited | 1.58 Billion INR | 62.898% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -351.829% |
| MedPlus Health Services Limited | 30.04 Billion INR | 98.043% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | 68.827% |
| Patidar Buildcon Limited | 94.27 Million INR | -523.769% |
| Roopa Industries Limited | 647.82 Million INR | 9.224% |
| Smruthi Organics Limited | 1.18 Billion INR | 50.244% |
| Trident Lifeline Limited | 870.76 Million INR | 32.466% |
| PANJON LTD. | 173.91 Million INR | -238.139% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | 35.619% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -152.675% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -518.208% |
| Anuh Pharma Limited | 4.45 Billion INR | 86.805% |
| Crestchem Limited | 71.44 Million INR | -723.135% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -572.619% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -12.194% |
| Tyche Industries Limited | 1.36 Billion INR | 57.044% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 80.882% |
| Trimurthi Limited | 73.64 Million INR | -698.468% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | 24.449% |
| Norris Medicines Limited | 141.87 Million INR | -314.5% |
| Zenlabs Ethica Limited | 402.58 Million INR | -46.072% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | 58.783% |
| ANG Lifesciences India Limited | 2.42 Billion INR | 75.744% |
| Parmax Pharma Limited | 176.12 Million INR | -233.888% |
| Veerhealth Care Limited | 281.16 Million INR | -109.15% |
| Deccan Health Care Limited | 1.08 Billion INR | 45.574% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 79.23% |
| Makers Laboratories Limited | 1.61 Billion INR | 63.532% |
| Lactose (India) Limited | 1 Billion INR | 41.625% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | 6.94% |
| Zenith Healthcare Limited | 97.41 Million INR | -503.681% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -35.482% |
| Bacil Pharma Limited | 13.26 Million INR | -4334.537% |
| PRAVEG LIMITED | 3.64 Billion INR | 83.871% |
| Denis Chem Lab Limited | 1.09 Billion INR | 46.221% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 85.082% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | 64.381% |
| Colinz Laboratories Limited | 113.59 Million INR | -417.689% |
| Godavari Drugs Limited | 1.34 Billion INR | 56.36% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -3241.083% |
| Zenotech Laboratories Limited | 1.06 Billion INR | 44.63% |
| Panchsheel Organics Limited | 1.59 Billion INR | 63.028% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | 65.597% |
| Vivanza Biosciences Limited | 195.01 Million INR | -201.55% |
| Phaarmasia Limited | 314.47 Million INR | -86.997% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 94.885% |
| Medi-Caps Limited | 1.27 Billion INR | 53.799% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -74.847% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | 73.404% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 76.499% |
| Mercury Laboratories Limited | 679.57 Million INR | 13.466% |
| Gennex Laboratories Limited | 2.29 Billion INR | 74.43% |
| BDH Industries Limited | 934.11 Million INR | 37.046% |
| Coral Laboratories Limited | 2.05 Billion INR | 71.409% |
| Bharat Parenterals Limited | 5.03 Billion INR | 88.328% |
| Beryl Drugs Limited | 174.86 Million INR | -236.288% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -1.427% |
| Evoq Remedies Limited | 368.61 Million INR | -59.536% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | 53.311% |
| Transchem Limited | 763.18 Million INR | 22.946% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -444.065% |
| Parnax Lab Limited | 1.88 Billion INR | 68.847% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -148.645% |
| Kerala Ayurveda Limited | 1.4 Billion INR | 58.263% |
| Cian Healthcare Limited | 1.61 Billion INR | 63.514% |
| Trinity League India Limited | 32.38 Million INR | -1715.797% |
| Syschem (India) Limited | 1.64 Billion INR | 64.149% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | 17.631% |
| Natural Capsules Limited | 3.76 Billion INR | 84.382% |
| Auro Laboratories Limited | 852.67 Million INR | 31.033% |